Inventor · disambiguated record
Eskil Elmer
Also filed as: ELMER ESKIL · ELMER ESKIL MATS · ELMÉR ESKIL
6 granted patents·5 pending applications·58 citations·filing 1996–2021
75Inventor score
Files withNEUROVIVE PHARMACEUTICAL AB5MAAS BIOLAB LLC2Abliva Ab1ELMÉR ESKIL1NEUROVIVE PHARMACEUTCAL AB1
Top patents by PatentIndex Score
11 records- 0175US5972924ATreatment of cerebral ischemia and cerebral damage with neuroprotective agentsMAAS BIOLAB LLC·Filed 1996·Granted Oct 26, 1999·55 cites·16 claims
- 0266US10307389B2Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylationNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Granted Jun 4, 2019·2 cites·4 claims
- 0365US12310940B2Cell-permeable succinate compoundsAbliva Ab·Filed 2021·Granted May 27, 2025·0 cites·19 claims
- 0454US7446093B1Cerebrospinal and vascular pharmaceutical composition and process for preparing the sameMAAS BIOLAB LLC·Filed 2000·Granted Nov 4, 2008·1 cites·10 claims
- 0546US2004147433A1Neuroimmunophilins for selective neuronal radioprotectionFiled 2004·Application pending·0 cites
- 0642US9040487B2Cyclosporine emulsionELMÉR ESKIL·Filed 2011·Granted May 26, 2015·0 cites·4 claims
- 0737US2015253306A1Mitochondrial toxicity testNEUROVIVE PHARMACEUTCAL AB·Filed 2013·Application pending·0 cites
- 0837US2019276481A1Liver Prodrugs of Mitochondrial Proton IonophoresNEUROVIVE PHARMACEUTICAL AB·Filed 2017·Application pending·0 cites
- 0936US11147789B2Cell-permeable succinate compoundsNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Granted Oct 19, 2021·0 cites·21 claims
- 1035US2015238563A1Cyclosporine emulsionNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Application pending·0 cites
- 1127US2017105960A1Prodrugs of Succinic Acid for Increasing ATP ProductionNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eskil Elmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →